Rocket will also collaborate with investigators to implement an immunomodulatory regimen more closely reflecting that administered in the Phase 1 pediatric cohort
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Skyhawk Therapeutics enters into an option agreement to grant Merck KGaA, Darmstadt, Germany, exclusive global rights to drug candidates pursued under the collaboration upon option exercise
Inclacumab was generally well tolerated in THRIVE-131
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
The submission is supported by positive results from the Phase 3 AMPLIFY trial
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
Subscribe To Our Newsletter & Stay Updated
